Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Noradrenergic influences on catalepsy

  • 21 Accesses

  • 28 Citations

Abstract

Widespread depletion of forebrain noradrenaline, produced by the intracerebral injection of 4 μg of 6-hydroxydopamine into the fibres of the dorsal noradrenergic bundle, potentiated the catalepsy induced by 20 mg/kg of morphine and severely attenuated the catalepsy induced by two separate cholinergic agonists, arecoline and pilocarpine. It did not, however, affect haloperidol catalepsy at any of the four doses tested. These results suggest that cholinergic catalepsy may be critically dependent on an intact noradrenergic substrate, perhaps through cholinergic receptors located either presynaptically on noradrenergic terminals or on the cell bodies of origin in the locus coeruleus. Noradrenaline appears to play a modulatory role in morphine catalepsy, although other sites of action must also be involved. Ascending noradrenergic systems do not appear to influence haloperidol catalepsy.

This is a preview of subscription content, log in to check access.

References

  1. Amatruda, T. T., Black, D. A., McKenna, T. M., McCarley, R. W., Hobson, J. A.: Sleep cycle control and cholinergic mechanisms: differential effects of carbachol injections at pontine brain stem sites. Brain Res. 98, 501–515 (1975)

  2. Atweh, S. F., Kuhar, M. J.: Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res. 129, 1–12 (1977)

  3. Baez, L. A., Eskridge, N. K., Schein, R.: Postnatal development of dopaminergic and cholinergic catalepsy in the rat. Eur. J. Pharmacol. 36, 155–162 (1976)

  4. Bird, S. J., Kuhar, M. J.: Iontophoretic application of opiates to the locus coeruleus. Brain Res. 122, 523–533 (1977)

  5. Bloom, A. S., Dewey, W. L., Harris, L. S., Brosius, K. K.: The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail flick test and increased synthesis of brain catecholamines. J. Pharmacol. Exp. Ther. 198, 33–41 (1976)

  6. Carmichael, F. J., Israel, Y.: In vitro inhibitory effects of narcotic analgesic and other psychotropic drugs on the active uptake of noradrenaline in mouse brain tissue. J. Pharmacol. Exp. Ther. 186, 253–260 (1973)

  7. Costall, B., Naylor, R. J.: On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia (Berl.) 34, 233–241 (1974a)

  8. Costall, B., Naylor, R. J.: A role for the amygdala in the development of the cataleptic and stereotypic actions of the narcotic agonists and antagonists in the rat. Psychopharmacologia (Berl.) 35, 203–213 (1974b)

  9. Costall, B., Naylor, R. J.: Serontonergic involvement with the stereotypy/catalepsy induced by morphine-like agents in the rat. J. Pharm. Pharmacol. 27, 67–69 (1975)

  10. Costall, B., Olley, J. E.: Cholinergic-and neuroleptic-induced catalepsy; modification by lesions in the caudate-putamen. Neuropharmacology 10, 297–306 (1971)

  11. Fukui, K., Takagi, H.: Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action. Br. J. Pharmacol. 44, 45–51 (1972)

  12. Janssen, P. A. J., Niemeegers, C. J. E., Schellekens, K. H. L.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? I. Arzneim. Forsch. 15, 104–112 (1965)

  13. Korf, J., Bunney, B. S., Aghajanian, G. K.: Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 25, 165–169 (1974)

  14. Kuschinsky, K., Hornykiewicz, O.: Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Eur. J. Pharmacol. 19, 119–122 (1972)

  15. Mason, S. T., Iversen, S. D.: Learning in the absence of forebrain noradrenaline. Nature 258, 422–424 (1975)

  16. McGeer, E. G., McGeer, P. L.: Catecholamine content of the spinal cord. Can. J. Biochem. 40, 1141–1151 (1962)

  17. Montel, H., Starke, K., Weber, F.: Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn-Schmiedebergs Arch. Pharmacol. 283, 357–369 (1974)

  18. Papp, M., Bozsik, G.: Comparison of the cholinesterase activity in the reticular formation of the lower brain stem of cat and rabbit. J. Neurochem. 13, 697–703 (1966)

  19. Pavlin R.: Cholinesterases in reticular nerve-cells. J. Neurochem 12, 515–518 (1966)

  20. Pert, C. B., Snyder, S. H.: Opiate receptor: demonstration in nervous tissue. Science 179, 1011–1014 (1973)

  21. Price, M. T. C., Fibiger, H. C.: Ascending catecholamine systems and morphine analgesia. Brain Res. 99, 189–193 (1975)

  22. Pycock, C.: Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat. Arch. Pharm. (Weinheim) 298, 15–22 (1977)

  23. Randrup, A., Munkvad, I.: Behavioural stereotypies induced by pharmacological agents. Pharmacopsychiatr. Neuropsychopharmakol. 1, 18–26 (1968)

  24. Reader, T. A., De Champlain, J., Jasper, H.: Catecholamines released from cerebral cortex in the cat: decrease during sensory stimulation. Brain Res. 111, 95–108 (1976)

  25. Reis, D. J., Rifkin, M., Corvelli, A.: Effects of morphine on cat brain norepinephrine in regions with daily monoamine rhythms. Eur. J. Pharmacol. 8, 149–152 (1969)

  26. Roberts, D. C. S., Fibiger, H. C.: Lesions of the dorsal noradrenergic projection attenuate morphine but not amphetamine-induced conditioned taste aversion. Psychopharmacology 55, 183–186 (1977)

  27. Scheibel, M. E., Scheibel, A. B.: Discussion in Brain Information Service Conference Report No. 32, Brain Information Service, Brain Research Institute, Los Angeles, 12–15 (1973)

  28. Shiomi, H., Takagi, H.: Morphine analgesia and the bulbospinal noradrenergic system: increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics. Br. J. Pharmacol. 52, 519–526 (1974)

  29. Timsit, J.: Sur l'activite cataleptigene de quelque derives de la butyrophenone. Therapie 21, 1453–1464 (1966)

  30. Uretsky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on noradrenaline-containing neurons in the rat brain. Nature 221, 557–559 (1969)

  31. Westfall, T. C.: Local regulation of adrenergic transmission. Physiol. Rev. 57, 659–728 (1977)

  32. Young, W. S., Bird, S. J., Kuhar, M. J.: Iontophoresis of methionineenkephalin in the locus coeruleus area, Brain Res. 129, 366–370 (1977)

  33. Zetler, G.: Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and anti-depressant drugs. Int. J. Neuropharmacol. 7, 325–335 (1968)

Download references

Author information

Correspondence to Stephen T. Mason.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mason, S.T., Roberts, D.C.S. & Fibiger, H.C. Noradrenergic influences on catalepsy. Psychopharmacology 60, 53–57 (1978). https://doi.org/10.1007/BF00429179

Download citation

Key words

  • Noradrenaline
  • Catalepsy
  • Morphine
  • Haloperidol
  • Pilocarpine
  • Locus coeruleus
  • Dorsal bundle
  • Arecoline